SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-078938
Filing Date
2024-03-27
Accepted
2024-03-27 17:07:27
Documents
2
Group Members
ORA CAPITAL LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d792279dsc13da.htm SC 13D/A 86432
2 EX-99.A d792279dex99a.htm EX-99.A 2840
  Complete submission text file 0001193125-24-078938.txt   90615
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Subject) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A | Act: 34 | File No.: 005-92205 | Film No.: 24791762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SILENCE THERAPEUTICS INC. 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address
Griffiths Richard Ian (Filed by) CIK: 0001846370 (see all company filings)

Type: SC 13D/A